Novation Holdings Inc. (NOHO)

[Hi_Lo]

NOHO is a "dilution scam" according to InvestorsHub's own Fraud Research Team.

Posted on April 17, 2017:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130522827

"Today ALZM still trades as NOHO and is still getting used as a dilution scam"

Other Gelmon scam companies:

CEO Michael J. Gelmon
Epicus Communications Group, Inc. EPCG
REVOKED BY THE SEC
Alberta Securities Commission - Cease Trade Order

CEO Michael J. Gelmon
Focus Gold Corporation
FGLF
REVOKED BY THE SEC
Alberta Securities Commission - Cease Trade Order

Safeguard Security Holdings, Inc.
Michael J. Gelmon Chairman and President
$0.0001; No Information, Skull & Crossbones

Solar Energy Initiatives, Inc
Michael J. Gelmon CEO
0.0001 x .0002; Stop Sign
Jan 16, 2014 Alberta Securities Commission - Cease Trade Order

Golden Patriot Corp - GPTC
Michael J. Gelmon President, Secretary, Treasurer, Director
0.0003; No Information, Skull & Crossbones
Feb 20, 2014 Alberta Securities Commission - Cease Trade Order

Banyan Corp.
Michael J. Gelmon President, Secretary, Treasurer, Director
0.0001; No Information, Skull & Crossbones
Feb 20, 2014 Alberta Securities Commission - Cease Trade Order

Novation Holdings, Inc. f/k/a Allezoe Medical Holdings, Inc (ALZM)
Michael J. Gelmon CEO
Michael Choo, director
Michael B. Holder, director
No bid x 0.0001
Jan 15, 2014 Alberta Securities Commission - Cease Trade Order


http://www.thehotpennystocks.com/articles/solar-energy-initiatives-inc-otcmktssnry-takes-a-step-back/

In a previous article we took a brief look at current SNRY CEO Mr. Michael Gelmon’s track record with previous OTC companies where he mostly served as CEO, as well as the total failure those enterprises turned out to be. This list includes Banyan Corp. (OTCMKTS:BNYN), Protocall Technologies, Inc. (OTCMKTS:PCLI), PaperFree Medical Solutions, Inc. (OTCMKTS:PFMS). What those businesses have in common is also the bitter pill of toxic financing which eventually drove them to their current status of around $0.0001 per share, and in the Pink No Information tier.

SNRY‘s own filings contain the name of Asher Enterprises, Inc. – an infamous entity that provided heavily toxic financing for other OTC companies in the past. Combining that with the fact that SNRY recently assumed a fair additional amount of convertible debt from a restaurant business, and then approved a twofold increase of their own authorized shares, the situation leaves very little to the imagination of traders and gives little hope that this latest venture of Mr. Gelmon will be a success.